Patent Rules

Version of section 116 from 2006-03-22 to 2007-06-01:

  •  (1) Modified nucleotides shall be listed in the sequence as “N”, with further information given elsewhere in the sequence listing.

  • (2) For the purpose of providing the further information referred to in subsection (1), the symbols set out in the table to this subsection may be used.

    TABLE

    SymbolMeaning
    ac4c4-acetylcytidine
    chm5u5-(carboxyhydroxymethyl) uridine
    cm2’-O-methylcytidine
    cmnm5s2u5-carboxymethylaminomethyl-2-thiouridine
    cmnm5u5-carboxymethylaminomethyluridine
    ddihydrouridine
    fm2’-O-methylpseudouridine
    gal qbeta, D-galactosylqueuosine
    gm2’-O-methylguanosine
    iinosine
    i6aN6-isopentenyladenosine
    m1a1-methyladenosine
    m1f1-methylpseudouridine
    m1g1-methylguanosine
    m1i1-methylinosine
    m22g2,2-dimethylguanosine
    m2a2-methyladenosine
    m2g2-methylguanosine
    m3c3-methylcytidine
    m5c5-methylcytidine
    m6aN6-methyladenosine
    m7g7-methylguanosine
    mam5u5-methylaminomethyluridine
    mam5s2u5-methoxyaminomethyl-2-thiouridine
    man qbeta, D-mannosylqueuosine
    mcm5s2u5-methoxycarbonylmethyl-2-thiouridine
    mcm5u5-methoxycarbonylmethyluridine
    mo5u5-methoxyuridine
    ms2i6a2-methylthio-N6-isopentenyladenosine
    ms2t6aN-((9-beta-D-ribofuranosyl-2-methylthiopurine-6-yl) carbamoyl) threonine
    mt6aN-((9-beta-D-ribofuranosylpurine-6-yl) N-methycarbamoy1) threonine
    mvuridine-5-oxyacetic acid-methylester
    o5uuridine-5-oxyacetic acid (v)
    osywwybutoxosine
    ppseudouridine
    qqueuosine
    s2c2-thiocytidine
    s2t5-methyl-2-thiouridine
    s2u2-thiouridine
    s4u4-thiouridine
    t5-methyluridine
    t6aN-((9-beta-D-ribofuranosylpurine-6-yl) - carbamoyl) threonine
    tm2’-O-methyl-5-methyluridine
    um2’-O-methyluridine
    ywwybutosine
    x3-(3-amino-3-carboxy-propyl) uridine, (acp3) u
Date modified: